ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 778 filers reported holding ASTRAZENECA PLC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $872,570 | -4.0% | 12,885 | +1.4% | 0.17% | -0.6% |
Q2 2023 | $909,175 | +3.2% | 12,703 | +0.1% | 0.17% | -3.9% |
Q1 2023 | $880,764 | -0.4% | 12,689 | -2.7% | 0.18% | -6.8% |
Q4 2022 | $884,156 | +19.0% | 13,041 | -3.8% | 0.19% | +0.5% |
Q3 2022 | $743,000 | -23.0% | 13,550 | -7.3% | 0.19% | -23.1% |
Q2 2022 | $965,000 | -0.9% | 14,611 | -0.5% | 0.25% | +9.3% |
Q1 2022 | $974,000 | +14.5% | 14,687 | +0.5% | 0.23% | +15.9% |
Q4 2021 | $851,000 | -2.4% | 14,617 | +0.7% | 0.20% | -16.3% |
Q3 2021 | $872,000 | +56.0% | 14,522 | +55.7% | 0.23% | +55.3% |
Q2 2021 | $559,000 | +27.9% | 9,324 | +6.1% | 0.15% | +14.5% |
Q1 2021 | $437,000 | +7.6% | 8,789 | +8.2% | 0.13% | -0.8% |
Q4 2020 | $406,000 | +20.1% | 8,123 | +20.4% | 0.13% | +3.1% |
Q3 2020 | $338,000 | -7.9% | 6,744 | -2.9% | 0.13% | -14.1% |
Q2 2020 | $367,000 | +4.3% | 6,945 | +1.5% | 0.15% | -3.9% |
Q1 2020 | $352,000 | -2.8% | 6,845 | -5.8% | 0.16% | +16.5% |
Q4 2019 | $362,000 | – | 7,263 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |